Anthropic
The frontier lab behind Claude shipped Fable 5 and Mythos 5 on June 9 — then the US government pulled both. A June 12 Commerce export-control directive forced a full global suspension three days after launch, citing a narrow jailbreak. As of June 27 (Day 15) Fable 5 remains fully offline for every commercial user; a June 26 Lutnick letter restored Mythos 5 to roughly 100 vetted US critical-infrastructure organizations only, and prediction markets moved up to 68-71% odds of full Fable restoration before July 1 (Anthropic's July 8 ID-verification policy is the likely US-gating mechanism). Fable 5 had topped the Artificial Analysis Intelligence Index at 95% SWE-bench Verified / 80.3% SWE-bench Pro before the takedown — the first government veto of a deployed commercial frontier model (dr already moved 2->3 at W25; held this week as the partial restoration cuts against a further downgrade). Series H closed at a $965B valuation (May 28, ~$47B annualized run-rate); a confidential S-1 is filed, and the lab separately accused Alibaba of a 28.8M-exchange distillation campaign (June 10 Senate letter). Capability leadership intact; dimensions at or near ceiling.
Key Investors
Scenarios
Safety-first brand becomes the enterprise default as regulation tightens. Opus 4.8 leadership and Mythos cyber capability set the frontier. Enterprise customers spending $1M+ annually grew from 12 to 1,000+ in two years; 41-day model cadence is the fastest premium-tier in the industry.
Capital-to-revenue ratio at $965B requires sustained hypergrowth; gross-vs-net dispute means $47B figure is annualized gross billing, not GAAP revenue. Massive capital requirements ($7B+ annual compute spend) with no clear path to profitability. Mythos cyber capability matched by GPT-5.5 within weeks — capability lead is generational, not lab-specific.
Key Factors to Watch
- ●Series H closed $65B at $965B (May 28) — overtakes OpenAI as largest private AI company; $15B of $65B is hyperscaler pre-committed capital
- ●$47B annualized gross billing run rate (May 28); gross-vs-net dispute unresolved — recognized revenue likely $33-40B
- ●Opus 4.8 + Dynamic Workflows (May 28) — 1,000 parallel subagents, Fast Mode 3x cheaper, 4x fewer missed coding flaws; 41-day cycle signals execution acceleration
- ●Mythos Preview 77.8% SWE-bench Pro / 73% AISI expert CTF — restricted-access via Project Glasswing; GPT-5.5 matched cyber score within weeks
- ●IPO prep active (Wilson Sonsini, capital-markets hires); summer-October 2026 NASDAQ target — at $965B among largest tech IPOs ever
Score History
| Date | Score | Direction | Note |
|---|---|---|---|
| 2026-06-21 | 8.8 | Very Positive | W25: Score 9.1→8.85 (dr 2→3). US Commerce export-control directive (June 12, 5:21pm ET) forced a full global suspension of Fable 5 + Mythos 5 for all users three days after launch, citing a narrow jailbreak; still offline as of June 20 with staff dispatched to Washington (markets price ~57% restoration before July 1). First demonstrated government veto of a deployed commercial frontier model — establishes a disruption-risk category not priced at dr 2. S-1 (filed June 1, $965B / $47B run-rate) and capability leadership intact. |
| 2026-05-30 | 9.1 | Very Positive | W22 data refresh — score holds 9.1 (dimensions saturated). Series H closed May 28: $65B at $965B post-money — overtakes OpenAI ($840B) as the most valuable private AI company. $47B annualized gross billing run rate disclosed (gross-vs-net dispute unresolved). Opus 4.8 + Dynamic Workflows shipped same day. Mythos Preview at 73% AISI cyber CTF (matched by GPT-5.5 within weeks). |
| 2026-05-16 | 9.1 | Very Positive | W20 data refresh — score holds 9.1 (dimensions saturated). ARR reported at $44B by May (Bloomberg, unconfirmed exact), $900B valuation raise in early talks, Mythos/Glasswing active with ~40 critical-infra partners, Gates Foundation $200M partnership. |
| 2026-03-08 | 9.1 | Very Positive | Initial assessment |
Software Peers
Last researched: 2026-06-27
This is research and analysis, not financial advice. Scores reflect AI impact potential, not investment recommendations.